MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down

Myriad Genetics, Inc. (MYGN) reported fourth-quarter 2024 adjusted earnings of 3 cents per share, which came in line with the Zacks Consensus Estimate. The company reported earnings of 4 cents per share in the year-ago quarter.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Adjusted earnings exclude amortization expenses from acquired intangible assets, equity compensations and real estate optimization. The GAAP loss was 47 cents compared with the prior-year quarter’s loss of 36 cents ...